An evaluation of the tumorigenicity of cyclophosphamide and urethan in newborn mice,☆☆

https://doi.org/10.1016/0041-008X(74)90042-8Get rights and content

Abstract

The tumorigenic potential of cyclophosphamide was compared with that of the known tumorigen urethan by ip administration of normal saline or 0.8, 4.0 or 20.0 mg/kg of cyclophosphamide or 700.0 mg/kg of urethan to newborn offspring of Charles River CD®-1 strain mice within 24 hr of birth and at 3 and 6 days of age. Tissues and organs from mice dying during the study or sacrificed at 79 weeks were examined grossly and microscopically. Cyclophosphamide was not leukemogenic. The incidence of malignant lymphoma was comparable for the control, low- and middle-dose groups and histologic evidence of this neoplastic disease was totally absent from the high-dose cyclophosphamide-treated mice. Liver neoplasms did not occur in the low- and high-dose cyclophosphamide groups, and the frequencies in the middle-dose group and the controls were similar. The frequency of pulmonary adenoma development was slightly increased in the low- and middle-dose cyclophosphamide-treated males and females and high-dose cyclophosphamide-treated females but neoplastic and hyperplastic lesions were totally absent from the lungs of the high-dose cyclophosphamide-treated males. Urethan was leukemogenic as malignant lymphomas developed in a high percentage of the urethan-treated male and female mice. The urethan-treated males also had an increased incidence of neoplasms and hyperplastic nodules in the lungs and liver.

References (31)

  • G.R. McKinney et al.

    Use of the life-table technique to estimate effects of certain steroids on probability of tumor formation in a long-term study in rats

    Toxicol. Appl. Pharmacol.

    (1968)
  • N. Brock et al.

    Zur Frage der carcinogenen Wirkung von Krebs-Chemotherapeutica und chemischen Immunsuppressiva

    Arzneim.-Forsch.

    (1971)
  • L. Chieco-Bianchi et al.

    Influence of age on susceptibility to liver carcinogenesis and skin initiating action by urethane in Swiss mice

    Brit. J. Cancer

    (1963)
  • J.T. Duhig

    Tumor incidence in A-Strain mice

    Arch. Pathol.

    (1965)
  • T.B. Dunn

    Normal and pathologic anatomy of the reticular tissue in laboratory mice, with a classification and discussion of neoplasms

    J. Nat. Cancer Inst.

    (1954)
  • L. Fiore-Donati et al.

    Leukaemogenesis by urethan in new-born Swiss mice

    Nature (London)

    (1961)
  • J.W. Gorrod et al.

    Induction of hepatomas by 4-aminobiphenyl and three of its hydroxylated derivatives administered to newborn mice

    J. Nat. Cancer Inst.

    (1968)
  • M.G. Kelly et al.

    Induction of tumors in newborn mice with dibenz[a,h]anthracene and 3-methylcholanthrene

    J. Nat. Cancer Inst.

    (1961)
  • H. Nordlinder

    Malformations after treatment of new-born mice with a single dose of cyclophosphamide

    Experientia

    (1969)
  • G. Pietra et al.

    Response of newly born mice to a chemical carcinogen

    Nature (London)

    (1959)
  • G. Pietra et al.

    The effects of carcinogenic chemicals on newborn mice

    Cancer

    (1961)
  • J.D. Prejean et al.

    Carcinogenicity studies of clinically used anticancer agents

  • P. Ranlov

    Effects of nitrogen mustard on the development of experimental amyloidosis in mice

    Acta Pathol. Microbiol. Scand.

    (1967)
  • F.J.C. Roe et al.

    Tumors of many sites induced by injection of chemical carcinogens into newborn mice. A sensitive test for carcinogenesis: The implications for certain immunological theories

    Brit. J. Cancer

    (1961)
  • F.J.C. Roe et al.

    Induction of liver and lung tumours in mice by 6-aminochrysene administered during the first 3 days of life

    Nature (London)

    (1969)
  • Cited by (7)

    • Genetic effects of cyclophosphamide, ifosf amide and trofosfamide

      1976, Mutation Research/Reviews in Genetic Toxicology
    • Noscapine-encapsulated nanopolymers: A novel drug-carrier system to target the tumor cells

      2012, International Journal of Green Nanotechnology: Biomedicine
    • Cyclophosphamide

      2011, IARC Monographs on the Evaluation of Carcinogenic Risks to Humans
    View all citing articles on Scopus

    Presented in part at the Twelfth Annual Meeting of the Society of Toxicology, New York, New York, March 18–22, 1973.

    ☆☆

    The research described in this report involved animals maintained in animal care facilities fully accredited by the American Association for Accreditation of Laboratory Animal Care.

    View full text